Mar 5, 2019
WOBURN, Mass.–(BUSINESS WIRE)–ReForm Biologics, a privately-held pharmaceutical technology company developing innovative biologic formulations to improve drug delivery and manufacturing, today announced a collaboration with Astellas Pharma Inc. (TSE:...
Jan 22, 2019
Cavallo Ventures, the venture capital arm of global agribusiness company Wilbur-Ellis, has just announced a seven figure investment in agricultural technology startup Crop Enhancement, Inc. The California-based company makes CropCoat, a unique protective coating being...
Jan 22, 2019
The venture capital arm of Wilbur-Ellis–a recognized leader in the marketing and distribution of crop protection, precision agriculture technology, seed and nutritional products–aims to accelerate the application of sustainable crop protection technologies...
Jan 14, 2019
The SoluPro E.coli manufacturing platform will be applied to two of Sanofi’s biologic candidates under a partnership deal with AbSci. Financial details of the deal have not been divulged, but the French Big Biopharma firm will use AbSci’s SoluPro expression platform...
Jan 10, 2019
VANCOUVER, Wash., Jan. 9, 2019 /PRNewswire/ — AbSci, a global leader in biotherapeutic discovery and manufacturing technologies, today announced a collaboration with Sanofi. Under the terms of the agreement, AbSci will apply its...
